Joudeh Naser Ahmad 4

4 · Medicine Man Technologies, Inc. · Filed Jul 12, 2021

Form 4

Period: 2021-03-03

Other

Transactions

Award
Warrant (Right to Buy)
2021-03-02+102,548→ 102,548 total
Exercise: $1.20From: 2020-03-02Exp: 2025-03-02→ Common stock (102,548 underlying)
Award
Warrant (Right to Buy)
2021-03-02+717,870→ 982,462 total(indirect: By Spouse)
Exercise: $1.20From: 2020-03-02Exp: 2025-03-02→ Common stock (717,870 underlying)
Award
Series A Cumulative Convertible Preferred Stock
2021-03-02$1000.00/sh+547$547,000→ 2,990 total
Exercise: $1.20→ Common stock (455,833 underlying)
Award
Series A Cumulative Convertible Preferred Stock
2021-03-02$1000.00/sh+547$547,000→ 7,683 total(indirect: By Spouse)
Exercise: $1.20→ Common stock (3,190,000 underlying)
Award
Series A Cumulative Convertible Preferred Stock
2021-03-02$1000.00/sh+865$865,000→ 3,855 total(indirect: By Spouse)
Exercise: $1.20→ Common stock (720,833 underlying)
Award
Warrant (Right to Buy)
2021-03-02+162,044→ 264,592 total(indirect: By Spouse)
Exercise: $1.20From: 2020-03-02Exp: 2025-03-02→ Common stock (162,044 underlying)

Footnotes (4)

[F1]Subject to adjustment, as described in the Certificate of Designation.
[F2]The shares of Series A Cumulative Convertible Preferred Stock (the "Series A Preferred Shares") are convertible into shares of the common stock (the "Common Shares") of Medicine Man Technologies, Inc. (the "Company") upon the events specified in the Company's Certificate of Designation of Series A Cumulative Convertible Preferred Stock (the "Certificate of Designation"). The Preferred stock is perpetual and therefore has no expiration date.
[F3]Represents the number of Common Shares issuable upon conversion of the Series A Preferred Shares on the date of the reported transaction. Each Series A Preferred Share is convertible into that number of Common Shares equal to the preference amount (initially $1,000) plus any accrued dividends with respect to such share, divided by the conversion price (initially $1.20), subject to adjustment as set forth in the Certificate of Designation. The Series A Preferred Shares earn a cumulative dividend of 8% per annum.
[F4]The reporting person received the warrants under Asset Purchase Agreements entered into by entities partly-owned by the reporting person upon the sale of assets by such entities to the issuer on the following date: March 3, 2021.

Documents

1 file